Search Login Register

Purpura Fulminans Summary

Description: A severe, rapidly fatal reaction occurring most commonly in children following an infectious illness. It is characterized by large, rapidly spreading skin hemorrhages, fever, or shock. Purpura fulminans often accompanies or is triggered by DISSEMINATED INTRAVASCULAR COAGULATION.

Also Known As: Fulminans, Purpura

Networked: 289 relevant articles (7 outcomes, 12 trials/studies) for this Disease

Key Drugs and Agents for Purpura Fulminans

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Protein C : 4 outcomes 9 studies in 88 results : IBA
  2. Antithrombin III : 2 outcomes 1 study in 6 results : IBA
  3. drotrecogin alfa activated (Xigris) : 1 outcome 1 study in 4 results : FDA 1
  4. Heparin (Liquaemin) : 1 outcome in 17 results : FDA 74 Generic
  5. Steroids : 1 outcome in 3 results : IBA
  6. Cortisone : 1 outcome in 3 results : IBA
  7. Ketoconazole (Nizoral) : 1 outcome in 1 result : FDA 20 Generic
  8. Etomidate : 1 outcome in 1 result : FDA 5 Generic
  9. Dacarbazine (DIC) : 1 study in 30 results : FDA 10 Generic
  10. Adrenal Cortex Hormones (Corticosteroids) : 1 study in 1 result : IBA
Show All >>

Diseases Related to Purpura Fulminans

  1. Sepsis (Septicemia)
  2. Septic Shock (Toxic Shock Syndrome)
  3. Purpura
  4. Adrenal Insufficiency (Adrenal Gland Hypofunction)
  5. Protein C Deficiency
Show All >>

Key Therapies for Purpura Fulminans

Efficacy Chart >>
  1. Hyperbaric Oxygenation : 1 outcome in 4 results
  2. Amputation : 24 results
  3. Catheters : 4 results
  4. Transplants (Transplant) : 4 results
  5. Splenectomy : 4 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.